| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPGI.2000.278.3.G354 |
| P698 | PubMed publication ID | 10712254 |
| P2093 | author name string | Green DR | |
| Lin T | |||
| Pinkoski MJ | |||
| Brunner T | |||
| P2860 | cites work | CD95-induced apoptosis in human liver disease | Q48027494 |
| Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. | Q50517174 | ||
| Cytotoxic reactivity of gut lamina propria CD4+ alpha beta T cells in SCID mice with colitis. | Q52045625 | ||
| Fas system and apoptosis in viral hepatitis. | Q53961575 | ||
| Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. | Q54341335 | ||
| Programmed cell death in Caenorhabditis elegans | Q57939597 | ||
| A role for CD95 ligand in preventing graft rejection | Q59066471 | ||
| Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer | Q22008593 | ||
| Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25 | Q22010467 | ||
| Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule | Q24305174 | ||
| Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c | Q24309066 | ||
| Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors | Q24310559 | ||
| Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade | Q24311006 | ||
| Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosis | Q24316216 | ||
| Inhibition of death receptor signals by cellular FLIP | Q24316446 | ||
| The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis | Q24316760 | ||
| Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3 | Q24324482 | ||
| Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death | Q24336389 | ||
| The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene | Q24336948 | ||
| Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
| Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development | Q24600961 | ||
| Fas-ligand: privilege and peril | Q24612227 | ||
| Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis | Q24679716 | ||
| Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity | Q24680778 | ||
| Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis | Q28250587 | ||
| A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD | Q28258328 | ||
| Mechanisms and Functions of Cell Death | Q28261655 | ||
| Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation | Q28263551 | ||
| Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex | Q28263687 | ||
| Death receptors: signaling and modulation | Q28280897 | ||
| FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex | Q28283294 | ||
| Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family | Q28285445 | ||
| Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis | Q28292299 | ||
| The role of c-FLIP in modulation of CD95-induced apoptosis | Q28293167 | ||
| IAP family proteins--suppressors of apoptosis | Q28297514 | ||
| Apoptosis by death factor | Q28304002 | ||
| Apaf1 is required for mitochondrial pathways of apoptosis and brain development | Q28505574 | ||
| Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis | Q28511080 | ||
| Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand | Q28513283 | ||
| Caspases: enemies within | Q29547315 | ||
| The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis | Q29616513 | ||
| Two CD95 (APO-1/Fas) signaling pathways | Q29619631 | ||
| An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome | Q33328425 | ||
| Apoptosis control by death and decoy receptors | Q33597389 | ||
| The central effectors of cell death in the immune system | Q33652530 | ||
| Suicidal tendencies: apoptotic cell death by caspase family proteinases | Q33684353 | ||
| The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. | Q33686145 | ||
| Gene transfer of Fas ligand induces tumor regression in vivo | Q33731661 | ||
| Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. | Q33834255 | ||
| Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. | Q33887189 | ||
| Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity | Q33980970 | ||
| The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene | Q34348941 | ||
| Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. | Q34348948 | ||
| Phagocyte recognition of cells undergoing apoptosis | Q34355692 | ||
| Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis | Q34451533 | ||
| Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein | Q42982436 | ||
| Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity | Q43605647 | ||
| CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance | Q44051217 | ||
| Role of Fas ligand in apoptosis induced by hepatitis C virus infection | Q45782023 | ||
| Human hepatocytes produce an isoform of FAS that inhibits apoptosis | Q46119181 | ||
| Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells | Q46642536 | ||
| Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. | Q46925453 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| Dissecting Fas signaling with an altered-specificity death-domain mutant: requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation | Q34986210 | ||
| Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. | Q35132088 | ||
| High Fas ligand expression on lymphocytes in lesions of ulcerative colitis | Q35351584 | ||
| Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase | Q35785971 | ||
| Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion | Q35786307 | ||
| Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. | Q36107808 | ||
| Expression of Fas ligand in liver metastases of human colonic adenocarcinomas | Q36186304 | ||
| DNA synthesis and proliferation by villous epithelial cells in fetal rats | Q36193354 | ||
| Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover | Q36236704 | ||
| The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity | Q36364849 | ||
| Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl | Q36365371 | ||
| Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. | Q36365423 | ||
| Metalloproteinase-mediated release of human Fas ligand | Q36365559 | ||
| Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease | Q36366324 | ||
| The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice | Q36366817 | ||
| The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand | Q36367323 | ||
| A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice | Q36367334 | ||
| Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity | Q36400613 | ||
| Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis | Q36404144 | ||
| Lethal effect of the anti-Fas antibody in mice | Q36696599 | ||
| Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes | Q36819033 | ||
| Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors | Q36852093 | ||
| Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis | Q37361932 | ||
| Fas ligand- mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease | Q37377818 | ||
| Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus | Q37385429 | ||
| Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation | Q39757810 | ||
| Fas and Fas ligand: lpr and gld mutations | Q40398275 | ||
| Genetics of programmed cell death in C. elegans: past, present and future. | Q40835187 | ||
| A vision of cell death: insights into immune privilege | Q40898578 | ||
| Regulation of the proinflammatory effects of Fas ligand (CD95L). | Q40992162 | ||
| Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism | Q41005798 | ||
| Downregulation of Fas ligand by shedding | Q41071790 | ||
| Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after Systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts | Q41109628 | ||
| Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. | Q41358742 | ||
| Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Q41371079 | ||
| CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95L. | Q41964046 | ||
| FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas | Q42020999 | ||
| Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. | Q42830166 | ||
| Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody | Q42942821 | ||
| Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing | Q42951871 | ||
| Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C. | Q42981045 | ||
| P433 | issue | 3 | |
| P304 | page(s) | G354-66 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | Fas and Fas ligand in gut and liver | |
| P478 | volume | 278 |
| Q42784240 | A novel transgenic mouse model of lysosomal storage disorder |
| Q28354314 | An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity |
| Q50136138 | Anti-Proliferative Activities of Vasicinone on Lung Carcinoma Cells Mediated via Activation of Both Mitochondria-Dependent and Independent Pathways |
| Q35679008 | Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice |
| Q34726887 | Blocking Fas ligand on leukocytes attenuates kidney ischemia-reperfusion injury |
| Q48573415 | Caspase inhibition reduces hepatic tissue factor-driven coagulation in vitro and in vivo |
| Q35058696 | Combined adenovirus-mediated artificial microRNAs targeting mfgl2, mFas, and mTNFR1 protect against fulminant hepatic failure in mice |
| Q73429443 | Constitutive over-expression of the insulin receptor substrate-1 causes functional up-regulation of Fas receptor |
| Q36959209 | Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction |
| Q38807619 | Cytotoxic reactions of CC531s towards liver sinusoidal endothelial cells: a microscopical study |
| Q37417486 | Death receptor signal transducers: nodes of coordination in immune signaling networks |
| Q38644997 | Detection of Necroptosis in Ligand-Mediated and Hypoxia-Induced Injury of Hepatocytes Using a Novel Optic Probe Detecting Receptor-Interacting Protein (RIP)1/RIP3 Binding |
| Q53035019 | Detection of apoptosis in vivo using antibodies against caspase-induced neo-epitopes. |
| Q53431419 | Distinct requirements for activation-induced cell surface expression of preformed Fas/CD95 ligand and cytolytic granule markers in T cells. |
| Q33194313 | EGF mediates protection against Fas‐induced apoptosis by depleting and oxidizing intracellular GSH stocks |
| Q36774486 | Endothelial Fas-Ligand in Inflammatory Bowel Diseases and in Acute Appendicitis |
| Q34736260 | Fas-induced apoptosis increases hepatocyte tissue factor procoagulant activity in vitro and in vivo. |
| Q33579574 | Fas/Fas ligand-mediated apoptosis in different cell lineages and functional compartments of human lymph nodes |
| Q53391845 | Fumonisin B(1)-induced alterations in cytokine expression and apoptosis signaling genes in mouse liver and kidney after an acute exposure. |
| Q30538996 | Granule exocytosis mediates immune surveillance of senescent cells. |
| Q39904098 | Hepatoprotection via the IL-6/Stat3 pathway |
| Q28508537 | Homeostatic imbalance between apoptosis and cell renewal in the liver of premature aging Xpd mice |
| Q39646739 | In vivo monitoring of liver damage using caspase-3 probe |
| Q40619270 | Induction of FAS ligand expression in a human hepatoblastoma cell line by HCV core protein |
| Q24597407 | Intestinal epithelial apoptosis initiates gut mucosal injury during extracorporeal membrane oxygenation in the newborn piglet |
| Q36384554 | Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. |
| Q37367797 | Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus |
| Q73839432 | Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody |
| Q42518229 | Modulation of selected cell signaling genes in mouse liver by fumonisin B1. |
| Q43716993 | NO-mesalamine protects colonic epithelial cells against apoptotic damage induced by proinflammatory cytokines |
| Q78679596 | Oxidative stress induces the expression of Fas and Fas ligand and apoptosis in murine intestinal epithelial cells |
| Q35580786 | Oxysterol-binding protein-related protein 8 (ORP8) increases sensitivity of hepatocellular carcinoma cells to Fas-mediated apoptosis |
| Q33439759 | Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome |
| Q34297976 | Protective effects of HFE7A, mouse anti-human/mouse Fas monoclonal antibody against acute and lethal hepatic injury induced by Jo2 |
| Q44533652 | Rat liver ischemia-reperfusion-induced apoptosis and necrosis are decreased by FK506 pretreatment |
| Q34205309 | Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). |
| Q35097404 | Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer |
| Q43369504 | Role of peroxisome proliferator-activated receptor-alpha in ileum tight junction alteration in mouse model of restraint stress |
| Q34912414 | Sensitizing antigen-specific CD8+ T cells for accelerated suicide causes immune incompetence |
| Q33640766 | Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4 |
| Q37257648 | Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. |
| Q36001216 | Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms |
| Q35009467 | TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. |
| Q46970968 | Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. |
| Q35782195 | The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy |
| Q37393827 | The role of apoptosis in immune hyporesponsiveness following AAV8 liver gene transfer |
| Q42252416 | Tumor necrosis factor α (TNF-α) receptor-I is required for TNF-α-mediated fulminant virus hepatitis caused by murine hepatitis virus strain-3 infection |
| Q33865593 | Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease |
| Q28566908 | iNOS enhances rat intestinal apoptosis after ischemia-reperfusion |
Search more.